Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently accepted at: Journal of Medical Internet Research

Date Submitted: Nov 30, 2025
Open Peer Review Period: Dec 1, 2025 - Jan 26, 2026
Date Accepted: Mar 17, 2026
(closed for review but you can still tweet)

This paper has been accepted and is currently in production.

It will appear shortly on 10.2196/88717

The final accepted version (not copyedited yet) is in this tab.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Randomized Trial Evaluating a Tailored eHealth Intervention for Symptom Management in Couples Managing Prostate Cancer During the COVID-19 Pandemic

  • Lixin Song

ABSTRACT

Background:

This randomized controlled trial evaluated the efficacy of the “Prostate Cancer (PCa) Education & Resources for Couples” (PERC) eHealth intervention to improving the outcomes for patients and their partners.

Methods:

We enrolled 280 dyads (560 individuals) of patients with localized PCa who recently completed treatment, and their partners. Dyads were randomized to PERC or a control group who accessed an an NCI PCa website. Validated questionnaires assessed quality of life (QOL, FACT-G total; primary outcomes) and FACT-G subdomains, symptom and psychosocial measures (secondary outcomes) at baseline and 4, 8, and 12 months (T1-T4). Multilevel linear mixed models tested intervention effects.

Results:

FACT-G total, subdomain, and overall overall psychosocial outcomes did not differ significantly between groups over time. PERC patients reported marginally higher physical QOL (95% CI: –0.1 to 1.9, d=0.33), better illness appraisal (95% CI: 0.0 to 0.4, d=0.38), lower pain (95% CI: –5.3 to –0.2, d=0.38) at T4, and less frequent fatigue across time (95% CI: –3.9 to –0.4). PERC partners reported less urinary symptom bother at T3 (95% CI: -1.0 to14.1, d=0.44). Discussion: PERC demonstrated exploratory benefits including patients’ improved physical QOL, less fatigue, lower pain, improved illness appraisal in patients, and less urinary bother in partners.


 Citation

Please cite as:

Song L

Randomized Trial Evaluating a Tailored eHealth Intervention for Symptom Management in Couples Managing Prostate Cancer During the COVID-19 Pandemic

JMIR Preprints. 30/11/2025:88717

DOI: 10.2196/preprints.88717

URL: https://preprints.jmir.org/preprint/88717

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.